IN8bio, Inc. (INAB)
NASDAQ·Healthcare·Biotechnology
$0.93
+12.06%
Mkt Cap $8.39M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+330.1%
Consensus $4.00 vs current $0.93
NASDAQ·Healthcare·Biotechnology
$0.93
+12.06%
Mkt Cap $8.39M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+330.1%
Consensus $4.00 vs current $0.93